Name: TSHA Balance Sheet - Taysha Gene Therapies Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TSHA - Taysha Gene Therapies, Inc.

USD | NASDAQ | Healthcare

TSHA Balance Sheet - Taysha Gene Therapies Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Cash And Short Term Investments
Cash And Equivalents	319.8	139.0	143.9	87.9	149.1	251.3	-
Restricted Cash	0.4	0.4	0.4	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-
Cash And Short Term Investments	319.8	139.0	143.9	87.9	149.1	251.3	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-
Prepaid Expenses	4.4	2.6	3.5	8.5	10.5	6.6	-
Non-Current Assets
Property, Plant & Equipment Gross	11.4	11.1	13.8	16.6	51.1	0.3	-
Accumulated Depreciation	4.7	3.6	3.0	1.6	0.5	0.0
Current Liabilities
Accounts Payable	6.3	3.6	6.4	10.9	21.8	2.0	-
Short Term Debt	-	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	50.1	43.9	40.5	38.0	37.2	-	-
Operating Lease Liabilities Non-Current	18.2	17.4	19.0	20.4	-	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	-	-	-
Additional Paid In Capital	958.4	677.9	587.9	402.4	331.0	312.4
Supplementary Data
Total Debt	50.1	43.9	40.5	38.0	37.2	-	-
Net debt	(269.7)	(95.1)	(103.4)	(49.9)	(111.9)	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19
Cash And Short Term Investments
Cash And Equivalents	276.6	319.8	297.3	312.8	116.6	139.0	157.7	172.7	124.0	143.9	164.3	45.1	63.4	87.9	34.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	5.2	4.4	2.2	3.1	3.7	2.6	3.4	3.3	4.2	3.5	5.5	9.0	8.9	8.5	8.7	10.6	10.3	10.5
Other Current Assets	1.0	0.8	0.5	0.7	0.5	0.3	0.5	0.2	0.1	0.3	0.4	0.5	0.5	0.5	0.4	0.7	0.9
Assets Held For Sale	-	-	-	-	-	-	-	2.0	2.0	2.0	2.0	-	-	-	-	-	-	-
Total Current Assets	282.3	324.6	300.0	316.3	120.7	142.1	161.6	178.5	130.6	149.9	171.8	54.1	72.4	96.4	43.0	76.8

Non-Current Assets
Property, Plant & Equipment Gross	11.4	11.4	11.2	11.1	11.1	11.1	11.5	14.1	14.0	13.8	13.8	16.5	16.6	16.6	65.2	62.0	55.9	51.1	40.8	34.0	2.5	0.3	-	-	-	-	-
Accumulated Depreciation	5.0	4.7	4.4	4.1	3.8	3.6	3.9	3.6	3.3	3.0	2.6	2.3	2.0	1.6	1.3	1.0	0.8
Property,Plant & Equipment Net	6.5	6.7	6.8	7.0	7.2	7.5	7.6	10.5	10.7	10.8	11.2	14.1	14.6	15.0	64.0	61.0
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	9.2	9.4	7.5	7.8	8.1	8.4	8.7	9.0	9.3	9.6	9.9	10.3	10.6	10.9	-	-
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.3	0.3	1.3	1.3	1.2	1.2	0.7
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	300.4	343.3	316.6	333.3	138.4	160.4	180.2	200.4	153.0	172.7	195.8	81.5	101.6	126.3	111.5	142.3	166.0

Current Liabilities
Accounts Payable	4.6	6.3	5.4	7.7	4.3	3.6	4.9	8.7	10.4	6.4	7.5	10.8	9.0	10.9	15.3	24.0	22.0	21.8	22.1	6.4	4.1	2.0	8.8	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	5.5	5.5	7.5	9.8	11.8	13.6	14.7	18.1	18.8	20.2	28.9	33.6	-	-	-
Operating Lease Liabilities Current	1.5	-	1.2	1.3	1.4	-	1.4	1.4	1.3	-	1.2	1.3	1.4	-	-	-
Accrued Expenses	3.0	9.4	5.3	4.1	2.5	5.2	3.9	2.9	1.6	3.4	2.7	2.0	1.2	2.5	4.9	4.6	2.2	7.7
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	20.1	26.6	28.6	25.3	22.6	26.2	29.3	34.2	38.6	36.8	180.5	50.6	54.5	62.8	33.1

Non-Current Liabilities
Long Term Debt	49.0	50.1	50.9	41.1	42.5	43.9	43.0	37.8	40.5	40.5	38.5	38.4	38.2	38.0	37.8	37.6	37.4	37.2	27.8	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	17.8	18.2	16.5	16.8	17.1	17.4	17.8	18.1	18.5	19.0	19.1	19.5	19.9	20.4	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	3.0	6.2	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	1.6	1.6	1.6	1.4	1.2	1.3	1.4	1.4	1.5	1.6	3.8	3.9	4.0	4.1	3.9	3.5
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	88.4	96.4	97.6	84.6	83.3	88.8	91.4	91.5	99.2	97.8	244.9	118.7	116.5	125.3	100.3	109.6

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	-	-	-	-	-	-
Additional Paid In Capital	964.7	958.4	903.6	900.1	681.2	677.9	674.6	664.5	591.2	587.9	511.6	406.5	404.1	402.4	357.1	352.3	336.5
Retained Earnings	(753.7)	(711.3)	(683.4)	(650.7)	(623.8)	(602.3)	(583.5)	(558.0)	(537.1)	(513.0)	(560.7)	(443.7)	(419.1)	(401.4)	(345.9)	(319.6)	(285.8)
Accumulated Other Comprehensive Income	1.0	(0.2)	(1.1)	(0.7)	(2.3)	(4.0)	(2.3)	2.4	(0.3)	-	-	-	-	-	-	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	211.9	246.9	219.0	248.7	55.1	71.5	88.8	108.9	53.8	74.9	(49.1)	(37.1)	(14.9)	0.9	10.7	32.5	50.7
Total Equity	211.9	246.9	219.0	248.7	55.1	71.5	88.8	108.9	53.8	74.9	(49.1)	(37.1)	(14.9)	0.9	10.7	32.5	50.7	95.4